rare skin condition
LEO Pharma initiates phase 2a trial of delgocitinib cream for rare skin condition
June 3, 2025Research and Development Dermatology, LEO Pharma, Skin, clinical trial, delgocitinib cream, rare skin condition
LEO Pharma has initiated a phase 2a trial investigating delgocitinib cream in adults with mild-to-severe palmoplantar pustulosis (PPP). The DELTA …
